血浆降钙素原高水平患者临床特征与预后:188例分析
该回顾性研究纳入2013年2月至2016年12月入住浙江大学医学院附属第二医院、入院48小时内血浆PCT>100 μg/L的患者188例,按28天预后分为生存组与死亡组。患者以脓毒症(91.0%)为主,ICU入住率70.7%,28天病死率38.8%。死亡组MODS、创伤/烧伤、心肺复苏后、机械通气及休克比例,主要诊断数目、APACHE II评分、SOFA评分及肝功能、凝血、心肌酶、乳酸水平均显著高于生存组,血小板计数显著低于生存组。多因素logistic回归显示高APACHE II评分(OR=1.290,95%CI 1.121-1.484,P=0.000)与MODS发生(OR=7.264,95%CI 1.762-29.941,P=0.006)可能是预后不良的独立预测因素。
要点
- 血浆PCT>100 μg/L患者28天病死率38.8%(73/188),主要诊断为脓毒症(91.0%),ICU入住率70.7%。
- 死亡组MODS发生率84.9% vs 生存组40.0%,休克发生率100.0% vs 60.0%,均显著高于生存组(P<0.05)。
- 多因素logistic回归显示高APACHE II评分(OR=1.290,95%CI 1.121-1.484,P=0.000)与MODS发生(OR=7.264,95%CI 1.762-29.941,P=0.006)可能是预后不良的独立预测因素。
- 死亡组APACHE II评分24(19,28)vs 生存组14(10,16),SOFA评分16.0(12.5,18.0)vs 9.0(6.0,12.0),均显著高于生存组(P<0.05)。
- 创伤、MODS、心搏骤停及血小板、乳酸、肝功能、凝血谱、心肌酶等指标与PCT>100 μg/L患者预后相关。
适用人群与场景
- 入院48小时内血浆PCT>100 μg/L的患者,年龄平均62(49,75)岁,男性68.1%(128/188)。
- 主要诊断为脓毒症(91.0%),其次为MODS(57.4%)、胸腹部大手术后(20.7%)、创伤/烧伤(13.8%)、心肺复苏后(6.4%)。
- 多数患者入住ICU(70.7%,133/188)。
诊断标准与关键阈值
- 血浆PCT>100 μg/L为纳入阈值。
红旗征与不能漏的情况
- 死亡组MODS发生率84.9% vs 生存组40.0%,创伤/烧伤26.0% vs 6.1%,心肺复苏后13.7% vs 1.7%,机械通气82.2% vs 40.9%,休克100.0% vs 60.0%,均显著高于生存组(P<0.05)。
- 死亡组APACHE II评分24(19,28)vs 生存组14(10,16),SOFA评分16.0(12.5,18.0)vs 9.0(6.0,12.0),主要诊断数目2.0(2.0,3.0)vs 2.0(1.0,2.0),均显著高于生存组(P<0.05)。
- 死亡组血小板计数62.00(21.50,111.00)×10⁹/L vs 生存组93.00(53.00,136.00)×10⁹/L,显著低于生存组(P<0.05)。
- 死亡组肝功能、凝血指标、心肌酶及乳酸水平显著高于生存组(P<0.05)。
研究设计与关键结果
- 回顾性研究,纳入188例入院48小时内血浆PCT>100 μg/L患者,28天生存115例、死亡73例,病死率38.8%。
- 死亡组与生存组比较:MODS 84.9% vs 40.0%,创伤/烧伤26.0% vs 6.1%,心肺复苏后13.7% vs 1.7%,机械通气82.2% vs 40.9%,休克100.0% vs 60.0%,主要诊断数目2.0(2.0,3.0)vs 2.0(1.0,2.0),APACHE II评分24(19,28)vs 14(10,16),SOFA评分16.0(12.5,18.0)vs 9.0(6.0,12.0),以及肝功能、凝血指标、心肌酶和乳酸水平均显著高于生存组,血小板计数显著低于生存组[62.00(21.50,111.00)×10⁹/L vs 93.00(53.00,136.00)×10⁹/L],均P<0.05。
- 多因素logistic回归显示高APACHE II评分(OR=1.290,95%CI 1.121-1.484,P=0.000)与MODS发生(OR=7.264,95%CI 1.762-29.941,P=0.006)可能是预后不良的独立预测因素。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对血浆PCT>100 μg/L的患者,应关注是否合并脓毒症、MODS、创伤/烧伤或心肺复苏后状态,并评估呼吸与循环功能不全。
- 入院时APACHE II评分高或发生MODS的患者预后较差,作者认为高APACHE II评分与MODS发生可能是预后不良的独立预测因素。
- 血小板、乳酸、肝功能、凝血谱及心肌酶等实验室指标与预后相关,可用于病情评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the clinical characteristics and prognosis of patients with high level of plasma procalcitonin (PCT > 100 μg/L), and to improve the clinician's understanding, diagnosis and treatment of this kind of patients.
METHODS: A retrospective study was conducted. The clinical data of patients with plasma PCT over 100 μg/L within 48 hours of admission admitted to Second Affiliated Hospital of Zhejiang University School of Medicine from February 2013 to December 2016 were collected, and the clinical characteristics were analyzed. The patients were divided into survival and death groups according to 28-day prognosis. The general data and laboratory parameters including vital signs, 24-hour urine output, routine blood test, blood biochemical tests, coagulation parameters, myocardial enzymes and arterial blood gas analysis were collected. The risk factors of mortality were analyzed using multi-logistic regression analysis.
RESULTS: 188 patients with high level of plasma PCT were enrolled. There were 128 male patients (68.1%) with the average age of 62 (49, 75) years. Most patients were admitted in intensive care unit (ICU, 70.7%, 133/188). Major diagnosis was sepsis (91.0%), followed by multiple organ dysfunction syndrome (MODS, 57.4%), post large operation of thorax and abdomen (20.7%), trauma/burns (13.8%) and post-cardiopulmonary resuscitation (CPR, 6.4%). Of all the 188 patients, 115 patients survived and 73 died with a mortality of 38.8%. The parameters in the death group, including the percentages of MODS (84.9% vs. 40.0%), trauma/burns (26.0% vs. 6.1%), post-CPR (13.7% vs. 1.7%), ventilator support (82.2% vs. 40.9%) and shock (100.0% vs. 60.0%), the numbers of principal diagnosis [2.0 (2.0, 3.0) vs. 2.0 (1.0, 2.0)], acute physiology and chronic health evaluation II score [APACHE II score: 24 (19, 28) vs. 14 (10, 16)] and sequential organ failure assessment (SOFA) score [16.0 (12.5, 18.0) vs. 9.0 (6.0, 12.0)], as well as liver function, coagulation parameters, myocardial enzymes and lactic acid (Lac) levels were significantly higher than those in the survival group, but the platelet (PLT) count in the death group was significantly lower than that in the survival group [×109/L: 62.00 (21.50, 111.00) vs. 93.00 (53.00, 136.00), all P < 0.05]. The parameters with statistical significance in the univariate analysis were enrolled in the multiple factor logistic regression analysis, which showed that patient with a high score of APACHE II [odds ratio (OR) = 1.290, 95% confidence interval (95%CI) = 1.121-1.484, P = 0.000] or the occurrence of MODS (OR = 7.264, 95%CI = 1.762-29.941, P = 0.006) at admission had a poor prognosis.
CONCLUSIONS: The primary patients with high levels of plasma PCT (> 100 μg/L) were diagnosed with sepsis, MODS, trauma and post-CPR, complicated with respiratory and circulatory insufficiency. These factors of trauma, MODS and cardiac arrest, and some laboratory parameters including PLT, Lac, liver function, coagulation spectrum, and cardiac enzymes were correlated with the prognosis of the patients with high levels of plasma PCT. High APACHE II score and the incidence of MODS might be independent predictors of poor prognosis in the patients with high levels of plasma PCT.
参考来源
- Pan C, Cui W, Zhou F, et al. [Clinical characteristics and prognosis in patients with high plasma level of procalcitonin: an analysis in 188 patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28743338. doi:10.3760/cma.j.issn.2095-4352.2017.07.008
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。